portfolio

FDA: We’re working to reduce the risks

The FDA’s first priority is patient safety. The FDA has been working for several years to reduce the risk of patient infections associated with reusable endoscopes — small, flexible lighted tubes that allow doctors to see inside patients and treat certain medical conditions in a less invasive manner than traditional surgery. The devices, which include …

FDA: We’re working to reduce the risks Read More »

How Automated Compounding Can Reduce Hospital Costs

The $200 million fund created to compensate victims of the 2012 meningitis outbreak tied to tainted drugs from the New England Compounding Center is an extreme example of how expensive compounding errors can be.   But compounding errors don’t have to cause multistate disease outbreaks in order to be costly. A single error can cost …

How Automated Compounding Can Reduce Hospital Costs Read More »

Clinical Perspectives in Compounding

Human Factors in Sterile Compounding Involving a Hospital Pharmacy In the April issue of JAMA Internal Medicine published last year¹, an outbreak of bacteremia due to Burholderia contaminans (BCC) was linked to intravenous fentanyl produced by the compounding pharmacy at Duke University Hospital. The blood cultures of 7 patients during a 7 day period were …

Clinical Perspectives in Compounding Read More »